Liver Transplantation

Article	Citations
Issue Information ‐ Author Checklist	57
Robotic liver transplantation: University of Modena experience	50
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	40
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	39
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	38
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	38
CAQ Corner: Deceased donor selection and management	37
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	37
Acute liver failure: Do we have a consensus regarding management?	36
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	36
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	35
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	35
Introducing the Certificate of Added Qualification (CAQ) Corner	34
Issue Information	34
Issue Information ‐ Instructions to Authors	34
Issue Information	34
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	31
Incidence and risk factors for chronic rejection in pediatric liver transplantation	30
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	29
Machine learning improves post-transplantation HCC recurrence prediction	28
Postoperative complications after liver transplantation: Are we making progress?	28
Three problems, two viruses, and one man with a vision and voice: Larry Kramer, medical activist	27
Impact of Acuity Circles Policy on ABO Blood Type-Related Waitlist Outcomes in Liver Transplantation	26
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	26
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	26

Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	25
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	25
Semaglutide is effective in achieving weight loss in liver transplant recipients	24
Making the best use of testing for blood phosphatidylethanol	24
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study	23
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	23
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	22
PRO: All patients should receive a palliative care consult during LT evaluation	22
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	22
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	22
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	21
Bariatric surgery post-liver transplantation: A Belgian nationwide study	21
PRO: Is the management of ACLF better in a liver-dedicated ICU?	21
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	21
Issue Information ‐ Author Checklist	21
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	21
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	20
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	20
Liver transplantation for pediatric liver malignancies	19
Erratum	19
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	19
When worlds collide	19
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	19
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	19
Issue Information ‐ Author Checklist	19
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	19
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	19
Those Donor Leucocytes Again? This Time It’s VITT!	19
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	18
Issue Information	18
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	18
Issue Information	18
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	17
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	17
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	17
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	17
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	17
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	17
Policy Corner: HCC exception update	16
From gut to graft: Can microbiota shape pediatric liver transplant outcomes?	16
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	16
Operational tolerance is not always permanent	16
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	16
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	16
Long‐term quality of life of living liver donors: A Japanese nationwide survey	16
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	16
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	16
	16
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	15
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	14

A new tool to predict future liver allograft dysfunction?	14
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	14
Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	14
Outcomes using steatotic liver grafts: Will machines score the final goal?	14
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	14
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand	14
Issue Information	14
Looking for literal improvement in liver transplant outcomes	14
Navigating the road to liver transplantation equity	13
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	13
Reply: ChatGPT and unknown clinical questions about liver transplantation	13
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	13
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	13
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	13
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	12
Decompensated cirrhosis but low MELD—Should we wait or refer for liver transplantation?	12
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	12
Issue Information ‐ Author Checklist	12
Issue Information ‐ Instructions to Authors	12
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	12
Issue Information	12
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	12
Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	12
Cannabis and liver transplant: We need to chill, man	12
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	11
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	11
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	11
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	11
HepB-CpG vaccination: An alternate strategy to lifelong antiviral therapy in patients transplanted for chronic hepatitis B	11
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	11
Priority for kidney after liver transplantation: A safety net for all?	11
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	11
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	11
Issue Information	10
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis	10
Bacterascites confers poor patient prognosis beyond MELD prediction	10
A New Hope for a New Year	10
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	10
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	10
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	10
Blood Pressure Variability Early After Liver Transplantation Predicts Long‐Term Mortality	10
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	10
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	10
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay	9
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	9
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	9
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	9
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	9
Policy Corner: Polycystic liver disease MELD exception update	9
Management of portal vein thrombosis in liver transplant candidates	9
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	9
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	9
Few-shot learning: A methodological bridge from pilot experiments to large-scale studies in refractory ascites research	9
No Salvation Without Regeneration	9
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	9
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease	9
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	9
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	8
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	8
Informatics-driven solutions for optimal care delivery in liver transplantation	8
Financial burden of cirrhosis is significantly reduced after liver transplantation	8
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	8
No transplant candidate left behind	8
Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Issue Information	8
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	8
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	8
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	8
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	8
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	8
Language Accessibility of Liver Transplantation Center Websites	8
Does hepatectomy technique matter?	7
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	7
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	7
Untangling the web of waitlist dropout in HCC	7
Portopulmonary hypertension: May we agree to disagree?	7
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	7

Issue Information ‐ Instructions to Authors	7
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Second thoughts about second opinions for liver transplantation	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	7
Erratum	7
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	7
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	7
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	7
Issue Information ‐ Instructions to Authors	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	7
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	7
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	7
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	7
Policy Corner: Cholangitis exception update	7
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	7
Reduced Discard Rates of Split Liver Grafts by Having a Combined Adult‐Pediatric LT Program	7
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	6
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	6
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	6
Offer Acceptance Patterns for Liver Donors Aged 70 and Older	6
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	6
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	6
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	6
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	6
Maximizing outcomes by donor-recipient age matching in liver transplantation	6
Barriers to liver transplant referral in safety net settings: A national provider survey	6
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	6
Geospatial analysis of liver donation after death by drug intoxication	6
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	6
Issue Information ‐ Instructions to Authors	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
“Winning the peace” against obesity in recipients of liver transplant	6
Anonymity: What does it mean and why is it important to anonymous living liver donors?	6
Fellows’ Corner	6
Reduction of hepatectomy times in Dutch organ procurement teams	6
Speaking of the (Barely Legal) Elephant in the Room: Herbal or Dietary Supplement–Related Acute Liver Failure	6
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	6
Creation of a new VA liver transplantation center increased access and retained care within the Veterans Health Administration	6
Efficiency of machine perfusion in pediatric liver transplantation	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
Use of Livers With Fibrosis Based on Donor Hospital Biopsy: Missed Opportunities?	5
Salvaging the fatty liver for transplant: is short duration NMP enough?	5
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	5
Issue Information ‐ Author Checklist	5
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	5
Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation	5
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	5
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	5
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	5
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	5
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	5
Long‐term follow‐up of living liver donors	5
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	5
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	5
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	5
Issue Information ‐ Author Checklist	5
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	5
Proposing a Framework to Assess the Methodological Quality of Prognostic Models	5
Organ monitoring and identification of ischemic liver injury during ex situ porcine liver machine perfusion – a randomized controlled study	5
Liver transplantation in well-selected patients with unresectable colorectal liver metastases	5
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	5
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
A scoping review of nonmedical barriers to living donor liver transplant	5
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	5
Issue Information	5
A Modified liver donor risk index for pediatric liver transplant recipients	5
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	5
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	5
Quantitative methods for optimizing patient outcomes in liver transplantation	5
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	5
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	5
Living donor liver transplantation in infants 6 kg or less: Impact of graft type and size on postoperative outcomes	5
Strategic leadership and financial governance in liver transplantation: Global insights from the international liver transplantation society congress 2025	4
Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high‐volume transplant center	4
CAQ Corner: Evolution of liver allocation policy	4
Policy Corner: Ischemic cholangiopathy associated with donation after cardiac death	4
Alloantibody and crossmatch in simultaneous liver and kidney transplantation: Is the jury still out?	4
Will This Liver Work? The “Ibis Redibis” of Machine Preservation Viability Assessment	4
Acute cellular rejection in liver transplantation recipients following coronavirus disease 2019 vaccination	4
Less salt and more water for children—not just dietary, but transplant management too	4
Timing is everything: sleeve gastrectomy and liver transplantation	4
Achieving Equity for Liver Transplantation Recipients With Chronic Kidney Disease	4
Closing time	4
Progress and challenges in assessing allograft health in liver transplantation	4
Pediatric living donor liver transplantation for small infants with biliary atresia using interposition portal vein grafts: A multicenter cohort study	4
Letter to the Editor: How does ex vivo liver perfusion help improve the outcomes of liver transplantation in donation after cardiac death donors?	4
Secondary Prophylaxis of Gastric Variceal Rebleeding: And the Winner Is….?	4